Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling

Identifying molecular residual disease (MRD) after treatment of localized lung cancer could facilitate early intervention and personalization of adjuvant therapies. Here, we apply cancer personalized profi ling by deep sequencing (CAPP-seq) circulating tumor DNA (ctDNA) analysis to 255 samples from...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer Discov
Huvudupphovsmän: Chaudhuri, Aadel A., Chabon, Jacob J., Lovejoy, Alexander F., Newman, Aaron M., Stehr, Henning, Azad, Tej D., Khodadoust, Michael S., Esfahani, Mohammad Shahrokh, Liu, Chih Long, Zhou, Li, Scherer, Florian, Kurtz, David M., Say, Carmen, Carter, Justin N., Merriott, David J., Dudley, Jonathan C., Binkley, Michael S., Modlin, Leslie, Padda, Sukhmani K., Gensheimer, Michael F., West, Robert B., Shrager, Joseph B., Neal, Joel W., Wakelee, Heather A., Loo, Billy W., Alizadeh, Ash A., Diehn, Maximilian
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2017
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5895851/
https://ncbi.nlm.nih.gov/pubmed/28899864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-17-0716
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk